These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8938818)

  • 1. Alcohol withdrawal and dopamine receptor sensitivity after prolonged abstinence.
    Wiesbeck GA; Davids E; Wodarz N; Thome J; Weijers G; Jakob F; Boening J
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Oct; 20(7):1171-80. PubMed ID: 8938818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Craving for alcohol and dopamine receptor sensitivity in alcohol-dependent men and control subjects.
    Wiesbeck GA; Weijers H-G ; Gross JP
    J Neural Transm (Vienna); 2000; 107(6):691-9. PubMed ID: 10943909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone response to the GABA-B agonist baclofen in 3-week abstinent alcoholics.
    Ozsoy S; Esel E; Turan T; Kula M
    Alcohol; 2007 Dec; 41(8):551-6. PubMed ID: 18047908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dopaminergic transmission on severity of withdrawal syndrome in alcoholism.
    Heinz A; Schmidt K; Baum SS; Kuhn S; Dufeu P; Schmidt LG; Rommelspacher H
    J Stud Alcohol; 1996 Sep; 57(5):471-4. PubMed ID: 8858544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone response to placebo, apomorphine and growth hormone releasing hormone in abstinent alcoholics and control subjects.
    Wiesbeck GA; Mueller T; Wodarz N; Davids E; Kraus T; Thome J; Weijers HG; Boening J
    Drug Alcohol Depend; 1998 Sep; 52(1):53-6. PubMed ID: 9788006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mu-opioid receptor variants and dopaminergic sensitivity in alcohol withdrawal.
    Smolka M; Sander T; Schmidt LG; Samochowiec J; Rommelspacher H; Gscheidel N; Wendel B; Hoehe MR
    Psychoneuroendocrinology; 1999 Aug; 24(6):629-38. PubMed ID: 10399772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol dependence, family history, and D2 dopamine receptor function as neuroendocrinologically assessed with apomorphine.
    Wiesbeck GA; Mauerer C; Thome J; Jakob F; Boening J
    Drug Alcohol Depend; 1995 Nov; 40(1):49-53. PubMed ID: 8746924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in dopamine receptor sensitivity in humans after heavy alcohol intake.
    Balldin J; Alling C; Gottfries CG; Lindstedt G; Långström G
    Psychopharmacology (Berl); 1985; 86(1-2):142-6. PubMed ID: 2862656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of the mu-opioid receptor in alcohol-dependent individuals.
    Rommelspacher H; Smolka M; Schmidt LG; Samochowiec J; Hoehe MR
    Alcohol; 2001 Jun; 24(2):129-35. PubMed ID: 11522434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for prolonged recovery of dopaminergic transmission after detoxification in alcoholics with poor treatment outcome.
    Heinz A; Lichtenberg-Kraag B; Baum SS; Graf K; Kruger F; Dettling M; Rommelspacher H
    J Neural Transm Gen Sect; 1995; 102(2):149-57. PubMed ID: 8748679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine support for a relationship between "novelty seeking" and dopaminergic function in alcohol-dependent men.
    Wiesbeck GA; Mauerer C; Thome J; Jakob F; Boening J
    Psychoneuroendocrinology; 1995; 20(7):755-61. PubMed ID: 8848521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine evidence for reduced dopamine receptor sensitivity in alcoholism.
    Balldin JI; Berggren UC; Lindstedt G
    Alcohol Clin Exp Res; 1992 Feb; 16(1):71-4. PubMed ID: 1348401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced dopaminergic function in alcoholics is related to severe dependence.
    Schmidt LG; Dettling M; Graef KJ; Heinz A; Kuhn S; Podschus J; Rommelspacher H
    Biol Psychiatry; 1996 Feb; 39(3):193-8. PubMed ID: 8837980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical gamma-aminobutyric acid type A-benzodiazepine receptors in recovery from alcohol dependence: relationship to features of alcohol dependence and cigarette smoking.
    Staley JK; Gottschalk C; Petrakis IL; Gueorguieva R; O'Malley S; Baldwin R; Jatlow P; Verhoeff NP; Perry E; Weinzimmer D; Frohlich E; Ruff E; van Dyck CH; Seibyl JP; Innis RB; Krystal JH
    Arch Gen Psychiatry; 2005 Aug; 62(8):877-88. PubMed ID: 16061765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further neuroendocrine evidence for reduced D2 dopamine receptor function in alcoholism.
    Balldin J; Berggren U; Lindstedt G; Sundkler A
    Drug Alcohol Depend; 1993 Apr; 32(2):159-62. PubMed ID: 8508726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopathological and behavioral correlates of dopaminergic sensitivity in alcohol-dependent patients.
    Heinz A; Dufeu P; Kuhn S; Dettling M; Gräf K; Kürten I; Rommelspacher H; Schmidt LG
    Arch Gen Psychiatry; 1996 Dec; 53(12):1123-8. PubMed ID: 8956678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium.
    Sander T; Harms H; Podschus J; Finckh U; Nickel B; Rolfs A; Rommelspacher H; Schmidt LG
    Biol Psychiatry; 1997 Feb; 41(3):299-304. PubMed ID: 9024952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in oxidative stress status during early alcohol withdrawal in alcoholic patients.
    Huang MC; Chen CH; Peng FC; Tang SH; Chen CC
    J Formos Med Assoc; 2009 Jul; 108(7):560-9. PubMed ID: 19586830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsensitive alpha-2-adrenoceptor function in male alcohol-dependent individuals during 6 months of abstinence.
    Berggren U; Fahlke C; Norrby A; Zachrisson O; Balldin J
    Drug Alcohol Depend; 2000 Jan; 57(3):255-60. PubMed ID: 10661676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity.
    Caputo F; Francini S; Brambilla R; Vigna-Taglianti F; Stoppo M; Del Re A; Leggio L; Addolorato G; Zoli G; Bernardi M
    Eur Neuropsychopharmacol; 2011 Jun; 21(6):450-6. PubMed ID: 21276717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.